7th Annual Oncolytic Virotherapy Summit
December 07-08, 2022
FUJIFILM Diosynth Biotechnologies is delighted to be a sponsor at the 7th Annual Oncolytic Virotherapy Summit, December 7-8, 2022, Boston, Ma. Stop by our booth and meet our team to learn more about FUJIFILM Diosynth Biotechnologies’ capabilities and how we can help you advance and deliver tomorrow’s medicines.
Join our Presentation – December 7, 2022 @ 12:30pm
Speaker – Ian Goodwin, Director Viral Gene Therapy Global Program Design team, FUJIFILM Diosynth Biotechnologies, College Station, Texas is speaking on MANUFACTURING PATHWAYS SUPPORTING USE OF VIRAL VECTORS FOR ONCOLOGICAL INDICATIONS
- Oncolytic viral vectors and virotherapy offer hope to unmet needs for a vast number of oncological indications. Oncolytic virotherapy brings both common and unique challenges with regards to virus-specific process, analytical, and quality considerations that must be overcome to support successful transition from lab to clinic. The challenges discussed today will focus on these key areas, drawing from both experience and forward-looking innovation pathways to reduce the cost and time from lab to GMP to clinic.